Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD
Mario Cazzola, Clive Page
Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mario Cazzola, Clive Page. An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD. Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Evidence-based eHealth for COPD
ERS practice guidelines for the diagnosis of asthma in children aged 5 to 16 years
Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?